EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GBS ‐ MeDIP : A method for the simultaneous identification of genetic and epigenetic variants in tumors

Fábio Pértille iD, Shiva Rezaei iD, Julia Uffenorde, Oliver Gimm, Mohammad Ali Hosseinpour Feizi iD, Luiz Lehmann Coutinho, Carlos Guerrero-Bosagna

FEBS Open Bio · 09.11.2026

DOI: 10.1002/2211-5463.70360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 09.11.2026. Verfasst von Fábio Pértille und 6 weiteren Autor:innen. Beteiligte Einrichtung: Physiogy and Environmental Toxicology Program, Institute of Organismal Biology, Uppsala University, Sweden. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Vetenskapsrådet, The Escher Fund for Autism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor development arises from combined genetic and epigenetic alterations, yet most sequencing approaches examine these layers independently. We present GBS‐MeDIP, a low‐input and cost‐efficient method that combines genotype‐by‐sequencing with methylated DNA immunoprecipitation to jointly identify single nucleotide polymorphisms (SNPs), copy number variations (CNVs), and differentially methylated regions (DMRs) within the same genomic fraction. The method was evaluated in two clinical contexts: gastric adenocarcinoma (a malignant epithelial tumor) and parathyroid adenoma (a benign endocrine tumor). In both case studies, we detected thousands of SNPs, with principal component analysis (PCA) revealing genetic divergence in gastric tumors and substantial inter‐individual genetic background differences in parathyroid samples. We identified many CNVs in both datasets, with CNVs more frequent in parathyroid tumors, showing a stronger representation in promoter regions than SNPs. Gastric cancer showed a balanced methylation profile, with four DMRs reaching false discovery rate (FDR) significance, whereas Mimpara‐treated parathyroid tumors displayed widespread hypermethylation, with all significant DMRs hypermethylated. These significant DMRs mapped to genes involved in immune regulation, chromatin function, DNA repair, and endocrine signaling. Annotation analysis demonstrated that, in both tissues, CNVs were enriched in promoter and exonic regions, whereas DMRs were preferentially located in intronic and intergenic regions, reflecting the CpG‐enriched reduced genomic fraction accessed by GBS‐MeDIP. Importantly, both datasets contained DMRs overlapping CNVs, highlighting the method's ability to reveal genetic confounders in methylation studies. Together, these results show that GBS‐MeDIP enables combined genomic and epigenomic profiling in heterogeneous clinical tumor samples.

Schlagwörter

Stichwörter der Autor:innen

GBS‐MeDIPepigeneticsgeneticsgenomic and epigenomic profilingmarker

Autor:innen und Institutionen

  • Physiogy and Environmental Toxicology Program, Institute of Organismal Biology, Uppsala University, Sweden.
  • Avian Behavioral Genomics and Physiology Group, Department of Physics, Chemistry and Biology (IFM), Linköping University, Sweden.
  • Animal Biotechnology Laboratory, Animal Science Department, University of São Paulo (USP)/Luiz de Queiroz College of Agriculture (ESALQ), Brazil.
  • Faculty of Natural Sciences, Department of Animal Biology, University of Tabriz, Iran.
  • Department of Medical Biochemistry and Cell Biology, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
  • Department of Surgical Science, Uppsala University, Sweden.

ORCID-Profile: Fábio Pértille, Shiva Rezaei, Mohammad Ali Hosseinpour Feizi

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Vetenskapsrådet
  • The Escher Fund for Autism
  • Svenska Forskningsrådet Formas
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Pértille, F., Rezaei, S., Uffenorde, J., Gimm, O., Hosseinpour Feizi, M. A., Coutinho, L. L., & Guerrero-Bosagna, C. (2026). GBS ‐ MeDIP : A method for the simultaneous identification of genetic and epigenetic variants in tumors. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70360

Vancouver

Pértille F, Rezaei S, Uffenorde J, Gimm O, Hosseinpour Feizi MA, Coutinho LL, et al. GBS ‐ MeDIP : A method for the simultaneous identification of genetic and epigenetic variants in tumors. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70360

BibTeX
@article{Prtille2026,
  author = {Pértille, Fábio and Rezaei, Shiva and Uffenorde, Julia and Gimm, Oliver and Hosseinpour Feizi, Mohammad Ali and Coutinho, Luiz Lehmann and Guerrero-Bosagna, Carlos},
  title = {GBS ‐ MeDIP : A method for the simultaneous identification of genetic and epigenetic variants in tumors},
  journal = {FEBS Open Bio},
  year = {2026},
  doi = {10.1002/2211-5463.70360}
}
Kostenlos starten →